Bioventus Reports First Quarter Financial Results

Q1 reported revenue of $123.9 million declined 4.3$0.04 per share compared to a loss of $0.08 in the prior-year periodNon-GAAP earnings* of$0.08 per share increased 33%Company reiterated revenue, Adjusted EBITDA* and Non-GAAP EPS* guidance for full year 2025 DURHAM, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today reported financial results ...